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INTRODUCTION
 Carcinoma of unknown primary origin (CUP) is 
a heterogeneous group of cancers defined by the 
presence of metastatic disease with no identified 
primary tumor at presentation.1 It comprised 2% 
of all cancer in recent year and occurring mostly in 
6th and 7th decade of life.2,3 The condition carries a 
poor prognosis with the average survival from 6 to 
9 months.4 An extensive search to find the primary 
tumor is usually carried out. Even after extensive 
investigations that include imaging, endoscopies 
and immunohistochemistry studies the frequency 
of detection of a primary tumor is only upto 30%.5 
Finding primary site not only have important 
bearing on therapeutic decisions by the physician4 
but it also has prognostic implications.6 Some tumors 
especially metastatic colonic adenocarcinoma even 
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Objectives: Carcinoma of unknown primary origin (CUP) is heterogeneous group of cancers. Role of 
gastrointestinal (GI) endoscopy in this entity is under investigated. Aim of  this  study was to evaluate yield 
of Colonoscopy and Esophagogastroduodenoscopy (EGD) in localizing primary tumor in patients with CUP.
Methodology: Patients with histopathologically proven CUP who underwent colonoscopy / EGD to find the 
primary tumor from December 2009 to December 2011 were included in the study. Abdominal symptoms 
and cytokeratin (CK) 7 and 20 markers were correlated with presence of primary in GI tract.
Results: After giving informed consent 86 patients were included in final analysis. All patients underwent 
colonoscopy while 60(70%) got EGD along with colonoscopy. Mean age was 55.10 +/-11.94 years with 
52(60%) male. Abdominal symptoms were present in 50%. CK7+/CK20- in 34(40%); CK7-/CK20+ in 2(2%) 
while CK7+/20+ in 7(8%) of metastatic tumor samples. Liver was metastatic site in 47(55%), Lymph node 
12(14%) and Ascites in 8(9%). Endoscopy detected primary in 6 (7%) patients with 3 each in stomach and 
colon. No association of abdominal symptoms and cytokeratin markers was found with presence of GI 
primary site. 
Conclusion: Yield of localizing primary lesion in the GI tract by pan-endoscopy was limited. Abdominal 
symptoms and cytokeratin markers do not predict presence of gastrointestinal malignancies.
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at stage 3 and 4 has a 5 year survival ranging from 
6% to 45%7 as opposed to hardly few months 
average survival for CUP.5
 Guidelines and practices differ regarding the 
use of gastrointestinal (GI) endoscopies in finding 
the primary site. European Society for medical 
oncology (ESMO) guidelines8 recommend these 
endoscopies only if GI symptoms are present while 
National Comprehensive Cancer Network (NCCN) 
suggest esophagogastroduodenoscopy (EGD) / 
colonoscopy should be symptom directed and in 
addition to that colonoscopies should be performed 
in cases of adenocarcinoma or carcinoma unspecified 
metastasizing to the liver. EGD is also indicated if 
suspicion of finding primary in the upper GI tract 
is high based on the patient’s symptoms or other 
laboratory or radiological parameters.8,9 Immune-
histochemistry with  cytokeratin (CK) markers 
like CK 7 and 20 are routinely used for the tissue 
specimen. CK 7/20 positivity and/or negativity 
influences the decision to perform upper or lower 
GI endoscopies as they may direct towards the 
primary site in the GI tract.4,8,10
 An invasive approach of EGD and colonoscopy 
must take into account the low yield of finding the 
primary. It therefore seems imperative to evaluate 
yield of these endoscopies in finding the primary 
site and whether any risk factors associated with 
presence of primary in GI tract. There is little data 
available related to yield of colonoscopy and EGD 
in determining the primary site in patients with 
CUP. The aim of our study was to evaluate the yield 
of colonoscopy and EGD in localizing primary tu-
mor in patients with CUP. It also looked into the 
association of abdominal symptoms and CK 7 and 
20 markers with the presence of GI primary.
METHODOLOGY
Patient and methods: This cross sectional study 
was conducted from December 2009 to December 
2011 at The Aga Khan University Hospital on 
patients diagnosed as having biopsy proven CUP 
defined by the presence of metastatic disease with 
no identified primary tumor at presentation. The 
study protocol was approved by the Hospital Ethics 
review committee.
 A total of 102 patients having CUP had colon-
oscopy and/ or EGD for GI symptoms, radiology 
and CK marker were enrolled after informed con-
sent. EGD and colonoscopy were performed based 
upon the history, site, histopathology, tumor mark-
ers and radiology findings. Patients with unknown 
primary and having these procedures for upper 
GI bleed and perforation were excluded from the 
study. Similarly patients with deranged coagula-
tion or on therapeutic anticoagulation were also ex-
cluded. Detailed history with particular emphasis 
on gastrointestinal related complaints like abdomi-
nal pain, bleeding per rectum and altered bowel 
habits were taken.  Physical examination was car-
ried out in every patient. All the data was collected 
on a predesigned questionnaire.
 EGD and colonoscopies were done under 
conscious sedation with intravenous midazolam 
and fentanyl by gastroenterologists with Olympus 
GIF-Q 180 video scope and Olympus CF 180 AL 
Colonoscope respectively. Normal coagulation 
was assured before these procedures. Pulse, Blood 
Pressure and oxygen saturation were monitored 
before the start of procedure and every five minutes 
till completion. Details on preparation of colon, 
nature and location of the lesions were recorded. 
All lesions found at endoscopies were biopsied and 
sent for histo-pathological examination. Specimens 
were examined by at least two histopathologists 
before reporting.
Statistical analysis: Descriptive statistics were 
calculated for continuous variables such as age, 
haemoglobin Mean ± SD were computed. For cat-
egorical variables such as gender, abdominal pain, 
biopsy site, histo-pathological type of lesion and 
radiological findings, the frequencies and percent-
ages were calculated. The chi-square test was ap-
plied to assess the association of different variables 
like abdominal symptoms, cytokeratin markers 
with the primary lesion.  P < 0.05 was considered 
significant. P value greater than this is reported as 
NS (Non-significant). Data entry and analysis were 
performed using the Statistical Packages for Social 
Sciences version 17(SPSS, Chicago, Illinois, USA).
RESULTS
 A total of 102 patients of CUP were detected 
during study period. Out of which 86 patients 
underwent endoscopic procedures and were 
considered for final analysis. Detail of the excluded 
patients is given in Fig.1.
 Of the 86 patients, the mean age of presentation 
was 55.10 +/- 11.94 years among which 71(82.5%) 
patients were from 41 to 69 years of age. The 
youngest patient was 23 years and the eldest was 85 
years at the time of diagnosis.  The male population 
comprised of 52 (60.46%) patients. Among all 86 
patients abdominal pain, altered bowl habits and 
bleeding per rectum were present in 46.5%, 14% 
and 7%, respectively. The basic demographics 
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along with the radiologic findings and CK markers 
distributions are given in Table-I.
 The mean hemoglobin was 11.36 gms/dl having 
normochromic and normocytic picture. The 
predominant metastatic site was liver in 47(55%) 
patients followed by lymph nodes in 12(14%) 
patients, respectively. (Table-II) Among the 7(8.13%) 
bone biopsies five were from the vertebrae, while 
one each from scapula and right iliac crest. The soft 
tissue biopsy sites included buttock and a forearm 
nodule. Single metastatic deposit was in ovary, 
prostate and urinary bladder. The histopathology 
of the metastatic deposit was predominantly either 
adenocarcinoma or various sub-types of the same. 
(Table-III)
 CK7 was positive in 34 (40%) while CK 20 was 
positive in 2 (2%) patients, respectively. CK 7/20 
positive in 7 (8%) patients while both were negative 
in 43 (50%). Two patients with both CK7 and 20 
positive were found to have malignancy in stomach 
and rectum, respectively. While among the two 
patients with CK7 positivity were found to have 
the primary in sigmoid and stomach respectively. 
The remaining two patients who were negative for 
both CK7 and CK20 had their primary found in 
stomach and transverse colon. The p-value for the 
cytokeratin markers with primary found in GI tract 
was found to be p = 0.46. (Table-IV)
 All patients 86(100%) underwent colonoscopy 
while 60 (70%) patients underwent EGD in addition 
to colonoscopy according to the inclusion criteria. 
Primary tumor was detected in 6 (7%) patients. In 
three (3.48%) patients primary tumor was found in 
the stomach while in remaining three it was in co-
lon. Among these three each has a malignancy in 
rectum, sigmoid and transverse colon respectively.
Out of the 86 colonoscopies 6(7%) patients had ei-
ther an ulcer or a mass in their colon. Three (50%) 
out of these 6 patients with abnormal findings got 
their primary identified as a result of biopsy. Sim-
ilarly out of 15 (17.4%) ulcers or a mass found at 
EGD, 3 (20%) turned out to be the source of primary.
Sub group analysis of the patients with 
adenocarcinoma of all categories along with 
unspecified carcinoma metastasizing to liver was 
done. There were a total of 44 patients among them 
Table-I: Demographics, Radiological 
and Cytokeratin markers.
Demographics, Symptoms,  n = 86 (%)
  radiological and tumor markers
Gender 
 Male 52 (60.46 )
 Female 34 (39.54 )
Age (years) 55.10 +/-11.94
Previous Malignancy 1 (1.1 )
Smoker 28 (32.55)
Alcohol 3 (3.48)
Weight loss 39(45.34)
Abdominal symptoms 43(50)
Hemoglobin (gms /dl) 11.36 ± 2.29
Radiological findings 
 Ascites 28  ( 32.55)
 Omental caking and mesenteric 26  (30.23)
   metastasis
 Vertebral metastasis 17  (19.76)
 Lymph nodes 37  (43.02)
 Hepatic metastasis 56  (65.11)
Cytokeratin markers 
 CK 7+/CK 20- 34(39.53)
 CK 7-/CK 20+ 2(2.32)
 CK7+/CK20+ 7(8.13)
 CK 7-/CK 20- 43(50)
Fig.1: Flow Chart.
Table-II: Site of metastatic involvement.
Biopsy site Frequency (%) Primary Primary
   on EDG on Colon
Liver 47 (54.65%) 1 1
Lymph nodes 12 (13.89%) 0 0
Ascitic fluid 8   (9.30%) 0 0
Bone 7   (8.13%) 0 0
Omentum 5   (5.81%) 0 1
Soft tissue 2    (2.2%) 1 0
Pleural fluid 2    (2.2%) 1 0
Viscera 3   (3.48%) 0 1
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25 (56.8%) had abdominal symptoms while 18(41%) 
of patients were CK7-/20-. One primary was found 
out as a result of colonoscopy in this particular 
group. The p value for abdominal symptoms and 
cytokeratin markers with respect to primary found 
in colon was 0.451 and 0.806 respectively.
DISCUSSION
 This study showed a yield of around 7% in CUP by 
virtue of EGD and colonoscopy.  However it failed 
to elaborate any co-relation between the different 
variables and EGD / colonoscopy with respect to 
this specific entity. The mean age of presentation 
in this study was  55 years as opposed to 59 years 
as reported from the literature from the West.3 In 
our study three patients were found to have cancer 
in the colon and in three patients the primary was 
found in the stomach. Overall there was no associa-
tion between the abdominal symptoms and finding 
the primary in the gastrointestinal tract however 
two out of the three patients with primary found in 
the colon had abdominal pain.
 In our study liver, lymph nodes and ascitic flu-
id were the most frequently involved sites for the 
metastatic disease respectively. In this regard Dis-
ibio et al in an autopsy based study concluded that 
lymph nodes are the most common site of metasta-
sis (20.6%).11 Several studies have quoted different 
frequency of organ involvement depending upon 
the histo-pathological types of the disease.12,13
 The expression of certain cytokeratin markers 
may help in differentiating the site of origin of dif-
ferent metastatic carcinomas. In our study, among 
three patients with metastatic colon cancers we 
found that CK 7 and 20 were both positive in one 
patient, both negative in another patient and the 
third patient had CK 7 positive with CK 20 negative. 
Previous studies have shown that CK 7 negativity 
with CK 20 positivity has the greatest predilection 
for colorectal cancers.14 However,  it has also been 
demonstrated that upto 17% of colon cancers are 
positive for CK 7 whereas upto 19% of these tumors 
are negative for CK 20.15 Hence although CK7+/
CK20- pattern in metastatic biopsy may point to-
wards gastric cancer primary yet its absence does 
not rule out the possibility of primary colorectal 
neoplasm.15
 In our study one out of three patients who had 
primary at stomach showed sole positivity for CK 7, 
none of the patients was sole CK 20 positive.  How-
ever, single patient with CK7/20 positivity found to 
have primary residing in the stomach. This was also 
shown in study done by Pavlidis N.10 In contrast to 
colorectal adenocarcinoma; gastric adenocarcino-
mas have a heterogeneous expression of CK7/20. 
Studies have shown that CK 7-/20- pattern is seen 
in 10% gastric cancers while CK20+/7- pattern is 
seen in upto 33% of gastric adenocarcinomas while 
the rest exhibit mixed pattern.14,16-18 We also did not 
find any association of finding CK 7 or CK 20 with 
the detection of primary tumor. This is most likely 
because of small number of primary tumors in our 
cohort or because of heterogeneity of expression of 
these markers as observed by others as well.
 It is interesting that there was no association of 
abdominal symptoms and detection of primary 
tumor in our study (p value NS). Studies have 
shown that patients with CUP mostly present with 
non specific symptoms of anorexia, weakness and 
Table-III: Histopathology of the metastatic site and their subsequent outcome on endoscopy.
Biopsy of metastatic site Primary tumor not found Primary found  on EGD Primary found on colon Total (%)
Adenocarcinoma 62 2 1 65 (75.58)
Poorly differentiated adenocarcinoma 4 1 1 6 (6.97)
Infiltrating adenocarcinoma 4 0 0 4 (4.65)
Neuroendocrine differentiation 3 0 0 3 (3.48)
Large cell carcinoma 2 0 0 2 (2.2)
Papillary carcinoma 2 0 0 2 (2.2)
Squamous cell carcinoma 1 0 0 1 (1.1)
Mucin secreting adenocarcinoma 1 0 0 1 (1.1)
Signet ring adenocarcinoma 0 0 1 1 (1.1)
Untype-able carcinoma 1 0 0 1 (1.1)
 80 3 3 86 (100%)
Table-IV: Correlation of abdominal symptoms and 
cytokeratin markers with the site of primary.
 Primary found Primary found P value
 at EGD at Colonoscopy
Abdominal symptoms 1 2 0.717
CK 7-/20- 1 1 
CK7+/20+ 1 1 0.469
CK7+/20- 1 1
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weight loss. Early dissemination and lack of specific 
clinical features are hall mark of these malignan-
cies. Moreover if there would have been prominent 
gastrointestinal symptoms those cases would have 
been detected earlier on with appropriate symptom 
directed investigations like colonoscopies and/or 
gastroscopies before their metastasis would come 
to lime light.
 Sub group of patients having adenocarcinoma 
or carcinoma unspecified metastasizing to liver 
which underwent colonoscopy as indicated by 
NCCN guidelines, shows a poor yield of only one 
primary found as a result of colonoscopy in this sub 
select group of patient. Furthermore there was no 
correlation between the abdominal symptoms and 
the cytokeratin markers with respect to the primary 
found in the GI tract. However these findings can 
happen because of the poor yield of finding the 
primary in the GI tract.
 We would like to highlight some of the limitations 
of this study. This was a single center tertiary 
care referral study. Our cohort consisted of small 
number of patients. But since CUP is not a very 
common disease it would be very difficult to recruit 
a large number of patients in a limited period of 
time. Endoscopies are operator dependent and 
carry a finite chance of missing a lesion depending 
upon bowl preparation and various other factors. 
Very limited number of patients had their primary 
found as a result of endoscopies. Hence getting a 
useful correlation in between the variables under 
consideration was difficult.
 Further studies are required so as to potentiate 
findings depicted in this study particularly those 
with higher number of patients having their pri-
mary known. Specifically those in which not only 
symptom, immune-histochemistry and radiological 
findings are taken into consideration.
CONCLUSION
 The yield of finding a primary lesion by 
gastroscopy and colonoscopy is limited. Abdominal 
symptoms and cytokeratin markers do not seem to 
reliably predict the presence of colonic or gastric 
malignancies. More studies with a larger sample 
size are needed to further validate our findings.
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